Anti-tachycardia pacing control in an implantable medical device system

US11666763B2 · kind B2 · utility

Assignee

• Medtronic, Inc. · US

Inventors

• Xusheng Zhang · Shoreview, US
• Yanina Grinberg · Plymouth, US
• Paul R. Solheim · Blaine, US
• Troy E. Jackson · New Brighton, US
• Timothy A. Ebeling · Circle Pines, US
• Vladimir P. Nikolski · Blaine, US

Key dates

• Filing date: Jun 8, 2020
• Grant date: Jun 6, 2023
• Expiry date: Jul 24, 2041

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61N1/3918
• WIPO field: Medical technology
• WIPO sector: Instruments

Abstract

An implantable medical device system is configured to detect a tachyarrhythmia from a cardiac electrical signal and start an ATP therapy delay period. The implantable medical device determines whether the cardiac electrical signal received during the ATP therapy delay period satisfies ATP delivery criteria. A therapy delivery module is controlled to cancel the delayed ATP therapy if the ATP delivery criteria are not met and deliver the delayed ATP therapy if the ATP delivery criteria are met.